Therefore, more sophisticated genetic tools and targeting strategies as well as more advanced cell-based model systems (e.g., patient-derived xenografts, organoids, refs. [101,102]) should be used in the future to dissect the molecular functions of MALAT1 and NEAT1 in pancreatic cancer. The gene discussed is MALAT1; the disease is pancreatic neoplasm.